INSIGHTS ON DRUG DEVELOPMENT

• Exosome Production From hMSC Using A Fixed-Bed Bioreactor

  Explore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.

• Inside Bioprocessing: Microbial Media

  Learn the reasons why the animal origin-free trend in bioprocessing has taken so long to reach microbial bioproduction and the technical hurdles overcome during the development of Gibco CD Bacto Supreme.

• Improving Swallowing And Palatability With Patient‑Friendly Forms

  Improve medication adherence and health outcomes by developing patient-friendly dosage forms that enhance swallowability and palatability for pediatric, geriatric, and dysphagic populations.

• Predicting Hepatotoxicity With The Liver-Chip

  Enhance your understanding of liver organoids and their pivotal role in enhancing DILI risk prediction through the use of advanced Organ-Chip technology.

• The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly

  3/3/2025

  In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.

• Amorphous Stability: Mesoporous Silica For Poor Glass Formers

  6/5/2025

  Discover how mesoporous silica outperforms polymeric solid dispersions in stabilizing poor glass formers, as well as how it offers a novel approach to enhance amorphous drug stability and bioavailability.

• Pioneers And Visionaries Of Nucleic Acid And Nanoparticle-Based Therapeutics

  12/12/2024

  Explore the future of nucleic acid and nanoparticle-based therapeutics, including mRNA, CRISPR, and gene editing, as experts discuss innovative solutions for complex health challenges.

• Establishing Commercial Manufacturing Services For ADCs

  6/3/2024

  Explore how one organization built upon 15+ years of experience and an extensive knowledge base of biologics manufacturing to establish commercial-scale ADC manufacturing capabilities.

• Polymorphism 101: What Early-Stage Drug Developers Need To Know To Reduce Risk

  5/18/2026

  Polymorphism impacts solubility, stability, and manufacturability, making early solid‑form screening critical to reduce risk, guide development decisions, and ensure consistent performance.